HUTCHMED (China) (HCM) Other Non-Current Liabilities (2015 - 2025)

HUTCHMED (China)'s (HCM) quarterly Other Non-Current Liabilities came in at $13.2 million in Q4 2025, up 358.53% year-on-year from $2.9 million in Q4 2024, and down 85.81% on a QoQ basis from $93.0 million in Q2 2025.

HUTCHMED (China) (HCM) Other Non-Current Liabilities (2015 - 2025) Analysis & Trends

HUTCHMED (China) (HCM) has 11 years of Other Non-Current Liabilities data on file, last reported at $13.2 million in Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 358.53% year-over-year to $13.2 million in Q4 2025; TTM through Dec 2025 was $13.2 million, a 358.53% increase from a year earlier, with the FY2025 full-year figure at $89.3 million, up 2016.78% from the prior year.
  • Other Non-Current Liabilities for Q4 2025 stood at $13.2 million, down from $93.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for HCM reached as high as $2.8 billion in Q4 2023 and fell as low as $2.9 million in Q4 2024.
  • Historically, Other Non-Current Liabilities has averaged $275.6 million across 5 years, with a median of $13.2 million in 2025.
  • Across the five-year window, Other Non-Current Liabilities soared 88088.42% in 2023 and sank 99.9% in 2024, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $7.0 million in 2021, then plunged by 53.73% to $3.2 million in 2022, then jumped by 88088.42% to $2.8 billion in 2023, then slumped by 99.9% to $2.9 million in 2024, then soared by 358.53% to $13.2 million in 2025.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $13.2 million in Q4 2025, $93.0 million in Q2 2025, and $2.9 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 HUTCHMED (China) 241.90 Mn 243.61 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 13.21 Mn
Jun 30, 2025 93.04 Mn
Dec 31, 2024 2.88 Mn
Jun 30, 2024 19.31 Mn
Dec 31, 2023 2.84 Bn
Jun 30, 2023 19.29 Mn
Dec 31, 2022 3.22 Mn
Jun 30, 2022 20.21 Mn
Dec 31, 2021 6.96 Mn
Jun 30, 2021 5.52 Mn
Mar 31, 2021 6.81 Mn
Dec 31, 2020 8.78 Mn
Jun 30, 2020 9.01 Mn
Dec 31, 2019 5.96 Mn
Sep 30, 2019 7.46 Mn
Jun 30, 2019 7.86 Mn
Mar 31, 2019 8.33 Mn
Dec 31, 2018 2.40 Mn
Jun 30, 2018 2.85 Mn
Dec 31, 2017 1.12 Mn